Check-Cap Ltd. (CHEK) Reaches $4.18 After 5.00% Down Move; Franklin Resources Has Decreased Eastman Chem Co (EMN) Holding

May 25, 2018 - By Kurt Siggers

Eastman Chemical Company (NYSE:EMN) Logo

The stock of Check-Cap Ltd. (NASDAQ:CHEK) is a huge mover today! The stock decreased 3.69% or $0.16 during the last trading session, reaching $4.18. About 479,525 shares traded. Check-Cap Ltd. (NASDAQ:CHEK) has declined 76.56% since May 25, 2017 and is downtrending. It has underperformed by 88.11% the S&P500.The move comes after 8 months negative chart setup for the $20.96M company. It was reported on May, 25 by We have $3.97 PT which if reached, will make NASDAQ:CHEK worth $1.05 million less.

Franklin Resources Inc decreased Eastman Chem Co (EMN) stake by 20.28% reported in 2017Q4 SEC filing. Franklin Resources Inc sold 113,144 shares as Eastman Chem Co (EMN)’s stock rose 13.33%. The Franklin Resources Inc holds 444,831 shares with $41.23 million value, down from 557,975 last quarter. Eastman Chem Co now has $15.11B valuation. The stock decreased 1.32% or $1.42 during the last trading session, reaching $105.85. About 364,703 shares traded. Eastman Chemical Company (NYSE:EMN) has risen 34.74% since May 25, 2017 and is uptrending. It has outperformed by 23.19% the S&P500.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $20.96 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. It currently has negative earnings.

More recent Check-Cap Ltd. (NASDAQ:CHEK) news were published by: which released: “Check-Cap up 13% on Q1 result” on May 17, 2018. Also Globes.Co.Il published the news titled: “Check-Cap plunges after raising $17.5m in Nasdaq offering” on May 06, 2018.‘s news article titled: “Your Daily Pharma Scoop: Cellectis Trial Protocol, Tesaro Takeover Rumor, Kitov Down Before PDUFA” with publication date: May 23, 2018 was also an interesting one.

Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap had 13 analyst reports since July 22, 2015 according to SRatingsIntel. Chardan Capital Markets maintained the shares of CHEK in report on Friday, May 20 with “Buy” rating. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, May 23. The stock has “Buy” rating by H.C. Wainwright on Thursday, September 28. H.C. Wainwright maintained the shares of CHEK in report on Thursday, January 11 with “Buy” rating. The company was maintained on Tuesday, November 28 by H.C. Wainwright. As per Wednesday, July 22, the company rating was maintained by Chardan Capital Markets. Maxim Group initiated the stock with “Buy” rating in Thursday, October 8 report. The firm earned “Buy” rating on Tuesday, March 13 by H.C. Wainwright. H.C. Wainwright maintained Check-Cap Ltd. (NASDAQ:CHEK) on Friday, August 11 with “Buy” rating. The stock of Check-Cap Ltd. (NASDAQ:CHEK) has “Buy” rating given on Tuesday, January 19 by Maxim Group.

Since February 7, 2018, it had 0 buys, and 11 selling transactions for $12.84 million activity. King Scott V. sold $996,437 worth of stock or 9,883 shares. 47,000 shares were sold by ESPELAND CURTIS E, worth $4.70M. 4,000 Eastman Chemical Company (NYSE:EMN) shares with value of $406,360 were sold by RAISBECK DAVID W. $2.62M worth of Eastman Chemical Company (NYSE:EMN) was sold by LICH BRAD A on Tuesday, May 8. Another trade for 4,000 shares valued at $399,360 was sold by DEMERITT STEPHEN R. 4,417 shares were sold by WARMACK DAMON CARY, worth $435,516. The insider COX MARK K sold 13,100 shares worth $1.38M.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.01, from 1.18 in 2017Q3. It dived, as 32 investors sold EMN shares while 187 reduced holdings. 74 funds opened positions while 182 raised stakes. 116.74 million shares or 0.76% more from 115.86 million shares in 2017Q3 were reported. Mckinley Cap Ltd Limited Liability Company Delaware has invested 0.01% of its portfolio in Eastman Chemical Company (NYSE:EMN). Qs Ltd Co invested in 7,502 shares. Moreover, M&T Retail Bank has 0.06% invested in Eastman Chemical Company (NYSE:EMN) for 127,157 shares. Ingalls & Snyder Ltd holds 4,618 shares. Ls Advsr Limited Com has invested 0.02% of its portfolio in Eastman Chemical Company (NYSE:EMN). Livforsakringsbolaget Skandia Omsesidigt accumulated 6,973 shares or 0.06% of the stock. Benjamin F Edwards And Company Incorporated owns 1,087 shares. Financial Architects holds 0% or 170 shares in its portfolio. Federated Investors Inc Pa reported 183,422 shares. 1.39M are held by Goldman Sachs. Rhumbline Advisers owns 274,994 shares. 3,034 are owned by Advsr Asset Mngmt Inc. Northern Trust has invested 0.04% in Eastman Chemical Company (NYSE:EMN). Parkside Retail Bank & holds 29 shares. Ftb owns 925 shares for 0.01% of their portfolio.

Analysts await Eastman Chemical Company (NYSE:EMN) to report earnings on July, 26. They expect $2.21 EPS, up 11.62% or $0.23 from last year’s $1.98 per share. EMN’s profit will be $315.50M for 11.97 P/E if the $2.21 EPS becomes a reality. After $2.23 actual EPS reported by Eastman Chemical Company for the previous quarter, Wall Street now forecasts -0.90% negative EPS growth.

More news for Eastman Chemical Company (NYSE:EMN) were recently published by:, which released: “Tracking Alex Roepers’ Atlantic Investment Management Portfolio – Q1 2018 Update” on May 24, 2018.‘s article titled: “Contractor change at Texas plant affects up to 229 KBR jobs” and published on May 16, 2018 is yet another important article.

Eastman Chemical Company (NYSE:EMN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: